Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1951 1
1962 1
1963 1
1973 3
1975 1
1977 3
1982 1
1983 2
1984 1
1985 1
1986 2
1988 1
1990 2
1991 2
1992 2
1993 2
1994 4
1995 4
1996 5
1997 7
1998 3
1999 3
2000 6
2001 4
2002 4
2003 9
2004 10
2005 5
2006 7
2007 8
2008 11
2009 9
2010 8
2011 11
2012 7
2013 5
2014 4
2015 4
2016 4
2017 4
2018 4
2019 7
2020 6
2021 5
2022 4
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Results by year

Filters applied: . Clear all
Page 1
Design of amidobenzimidazole STING receptor agonists with systemic activity.
Ramanjulu JM, Pesiridis GS, Yang J, Concha N, Singhaus R, Zhang SY, Tran JL, Moore P, Lehmann S, Eberl HC, Muelbaier M, Schneck JL, Clemens J, Adam M, Mehlmann J, Romano J, Morales A, Kang J, Leister L, Graybill TL, Charnley AK, Ye G, Nevins N, Behnia K, Wolf AI, Kasparcova V, Nurse K, Wang L, Puhl AC, Li Y, Klein M, Hopson CB, Guss J, Bantscheff M, Bergamini G, Reilly MA, Lian Y, Duffy KJ, Adams J, Foley KP, Gough PJ, Marquis RW, Smothers J, Hoos A, Bertin J. Ramanjulu JM, et al. Among authors: guss j. Nature. 2018 Dec;564(7736):439-443. doi: 10.1038/s41586-018-0705-y. Epub 2018 Nov 7. Nature. 2018. PMID: 30405246
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL. Ross S, et al. Among authors: guss j. J Psychopharmacol. 2016 Dec;30(12):1165-1180. doi: 10.1177/0269881116675512. J Psychopharmacol. 2016. PMID: 27909164 Free PMC article. Clinical Trial.
Letter to the Editors.
Guss J, Sloshower J. Guss J, et al. Psychodyn Psychiatry. 2024 Jun;52(2):237-238. doi: 10.1521/pdps.2024.52.2.237. Psychodyn Psychiatry. 2024. PMID: 38829229 No abstract available.
The science is in the data.
Helliwell JR, McMahon B, Guss JM, Kroon-Batenburg LMJ. Helliwell JR, et al. Among authors: guss jm. IUCrJ. 2017 Oct 6;4(Pt 6):714-722. doi: 10.1107/S2052252517013690. eCollection 2017 Nov 1. IUCrJ. 2017. PMID: 29123672 Free PMC article. Review.
Links Between the Microbiome and Bone.
Hernandez CJ, Guss JD, Luna M, Goldring SR. Hernandez CJ, et al. Among authors: guss jd. J Bone Miner Res. 2016 Sep;31(9):1638-46. doi: 10.1002/jbmr.2887. Epub 2016 Jul 26. J Bone Miner Res. 2016. PMID: 27317164 Free PMC article. Review.
Lower-dose psycholytic therapy - A neglected approach.
Passie T, Guss J, Krähenmann R. Passie T, et al. Among authors: guss j. Front Psychiatry. 2022 Dec 2;13:1020505. doi: 10.3389/fpsyt.2022.1020505. eCollection 2022. Front Psychiatry. 2022. PMID: 36532196 Free PMC article. Review.
Neuroimaging of toxic and metabolic disorders.
Arora A, Neema M, Stankiewicz J, Guss ZD, Guss JG, Prockop L, Bakshi R. Arora A, et al. Among authors: guss jg. Semin Neurol. 2008 Sep;28(4):495-510. doi: 10.1055/s-0028-1083684. Epub 2008 Oct 8. Semin Neurol. 2008. PMID: 18843577 Review.
194 results